Samjin Pharmaceutical said on the 25th it reappointed co-CEOs Cho Gyu-seok and Choi Ji-hyun as inside directors. The two are the eldest son and eldest daughter of co-founders Chair Cho Ui-hwan and Chair Choi Seung-hwan.
Samjin Pharmaceutical made the decision at its 58th annual general meeting held in Mapo District, Seoul, on the morning of the previous day. It also appointed outside director Min Kyung-hoon, former dean of the College of Pharmacy at Chung-Ang University.
The company set a mid- to long-term growth strategy centered on improving profitability, strengthening research and development (R&D), and solid management. Cho said, "A grave management environment is expected this year," adding, "We will work to turn the crisis into an opportunity."
Samjin Pharmaceutical will soon pay cash dividends of 800 won per common share to shareholders. The dividend yield is 3.9%. A Samjin Pharmaceutical official said the dividends were decided to enhance shareholder value.